The Diagnosis and Clinical Management of Immune-Mediated Liver Diseases: Recent Advances and Controversies



This dedicated EASL School in rare immune-mediated liver diseases, including PBC, AIH, PSC, IgG4-related disease, liver disease in patients with primary immunodeficiency and in patients treated with immune checkpoint inhibitors. The course will follow an inverted classroom model and will rely on local expertise from the Sheila Sherlock Liver Centre at the Royal Free Hospital and the UCL Institute for Liver and Digestive Health. Over 2 days participants will have the opportunity to learn about the state-of-the-art management and the approach to clinical controversies in this challenging area of hepatological practice. Participants will then undertake clinical case-based group sessions - the feedback sessions will then form the basis of interactive panel discussion amongst participants and faculty.

The course will end with group working on the cases with facilitators (pathology, radiology, transplant surgeons) and overview by prof. Massimo Pinzani "Distinct Mechanisms and Common Pathways in Liver Fibrosis Associated with Immune-Mediated Liver Injury: Relevance to Staging, Prognosis and New Therapies"


June 1-2, 2022


London, United Kingdom